Antenatal and intrapartum nucleic acid amplification test use for group B Streptococcus screening-United States, 2016

Diagn Microbiol Infect Dis. 2019 Jun;94(2):157-159. doi: 10.1016/j.diagmicrobio.2018.11.026. Epub 2018 Dec 11.

Abstract

Perinatal group B Streptococcus (GBS) disease prevention guidelines in 2010 allowed for processing of screening specimens by nucleic acid amplification tests (NAATs); however, the extent of NAAT use is unknown. A 2016 laboratory survey sent to 10 surveillance sites found that 18.7% of responding laboratories offered NAAT for GBS screening (antenatal only: 7.3%; intrapartum only: 4.1%; both: 3.4%).

Keywords: Antenatal; GBS; Intrapartum; NAAT; Screening.

MeSH terms

  • Female
  • Humans
  • Molecular Diagnostic Techniques / statistics & numerical data*
  • Nucleic Acid Amplification Techniques / statistics & numerical data*
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis*
  • Prenatal Diagnosis / statistics & numerical data*
  • Procedures and Techniques Utilization*
  • Streptococcal Infections / diagnosis*
  • Streptococcus agalactiae / genetics
  • Streptococcus agalactiae / isolation & purification*
  • United States